Fmoc-L-Asn(EDA-N3)-OH is an azide-bearing asparagine ADC linker intermediate supporting bioorthogonal click conjugation, improving site-specific antibody modification and controlled payload release in ADCs.
Structure of 2616562-74-2
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Fmoc-L-Asn(EDA-N3)-OH, a specialized amino acid derivative, plays a pivotal role in peptide synthesis and diverse biochemical applications. Here are four key applications of this compound:
Solid-Phase Peptide Synthesis: Serving as a fundamental component in solid-phase peptide synthesis, Fmoc-L-Asn(EDA-N3)-OH acts as a protected building block for amino acids. Its distinctive azide group (N3) allows for site-specific modifications and conjugations post-peptide assembly, particularly beneficial in the intricate design of complex peptides and proteins for both research and therapeutic endeavors.
Click Chemistry: With its distinctive azide group, Fmoc-L-Asn(EDA-N3)-OH finds relevance in click chemistry applications, enabling interactions with alkyne-containing molecules through copper-catalyzed azide-alkyne cycloaddition (CuAAC). This unique feature facilitates the precise and efficient attachment of various tags, probes, or other functional groups to peptides, advancing the exploration of protein interactions, localization, and bioconjugation processes.
Drug Development: In the realm of drug development, Fmoc-L-Asn(EDA-N3)-OH plays a crucial role in synthesizing peptide-based therapeutic candidates. By incorporating this modified amino acid, researchers can introduce novel functional groups that enhance drug properties such as stability, bioavailability, and target specificity.
Bioconjugation: This compound also holds notable value in bioconjugation initiatives, enabling the linkage of proteins or peptides to other biomolecules or surfaces. Its reactive functional groups empower the formation of conjugates with antibodies, enzymes, or nanoparticles, fostering the development of bioconjugates employed in various applications, including diagnostics, targeted drug delivery, and imaging, marking a significant stride in the realm of biotechnological advancements.
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.